Cipla to support Terra Carta, for sustainable future
Advertisement
Mumbai: Cipla Limited today announced that the company has pledged support to 'Terra Carta', a landmark charter that has been drawn up to put sustainability at the heart of the private sector. The charter is part of HRH The Prince of Wales' Sustainable Markets Initiative that was launched in Davos in 2020, with founding partners such as Bank of America, HSBC, BP and NatWest among others.
Since its launch in January 2021, the initiative has received support from 223 private sector organisations and 21 professional associations. Cipla is one of the five Indian companies and the only Indian pharmaceutical company to participate.
While continuing to achieve its own environmental, social and governance (ESG) goals, Cipla would also have the opportunity to drive ESG discourse within the sector and at a regional level. At the same time, the initative would allow participating organizations to cross-learn from one another.
Mr Umang Vohra, MD & Global CEO, Cipla said "Achieving sustainable and equitable growth is one of the greatest challenges and the need of this century. The pandemic has shown what can be achieved with the power of the collective, and the healthcare and the pharma sector has been at the forefront of it. I commend HRH Prince of Wales for leading Terra Carta and bringing together business leaders on Agenda 2030. We are committed to contributing to these goals and look forward to working alongside other sectors and business leaders".
Since FY19, Cipla has added 48 MW of solar energy portfolio through various initiatives such as an on-site roof top or ground mounted solar under RESCO model, third party solar open access power purchase agreement, and group captive solar open access project. The Company recently set up a 30 MW solar group captive project spread across 11 acres in Tuljapur, Maharashtra, making it one of the largest solar open access projects in the state set up by a corporate. By 2025, Cipla plans to achieve carbon and water neutrality, zero-waste to landfill, anti- microbial resistance stewardship and green chemistry.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.